{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:48:57Z","timestamp":1792691337786,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,1]],"date-time":"2027-04-01T00:00:00Z","timestamp":1806537600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["P30 DK072482"],"award-info":[{"award-number":["P30 DK072482"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL152960"],"award-info":[{"award-number":["HL152960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK054759"],"award-info":[{"award-number":["P30 DK054759"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["75N92025C00007"],"award-info":[{"award-number":["75N92025C00007"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["HL165404"],"award-info":[{"award-number":["HL165404"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["R35HL135816"],"award-info":[{"award-number":["R35HL135816"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["ENGELH21XX0"],"award-info":[{"award-number":["ENGELH21XX0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["CFF\/ROWE19R0"],"award-info":[{"award-number":["CFF\/ROWE19R0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymthe.2025.12.040","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:04:07Z","timestamp":1766563447000},"page":"2044-2062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["LUNAR LNP delivery of CFTR mRNA restores channel function and improves mucociliary clearance in ferret cystic fibrosis airways"],"prefix":"10.1016","volume":"34","author":[{"given":"Xiaoming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Campos-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourabh","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Snow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefen A.","family":"Boehme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2389-9277","authenticated-orcid":false,"given":"John F.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.040_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41572-024-00538-6","article-title":"Cystic fibrosis","volume":"10","author":"Mall","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2025.12.040_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1223012","article-title":"A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia","volume":"337","author":"Button","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.040_bib3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.20120562","article-title":"Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype","volume":"209","author":"Gustafsson","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(23)01609-4","article-title":"CFTR modulator therapy: transforming the landscape of clinical care in cystic fibrosis","volume":"402","author":"Taylor-Cousar","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.12.040_bib5","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-med-042921-021447","article-title":"Cystic Fibrosis Modulator Therapies","volume":"74","author":"Jia","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jcpt.13329","article-title":"A current review of the safety of cystic fibrosis transmembrane conductance regulator modulators","volume":"46","author":"Gavioli","year":"2021","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1513\/AnnalsATS.201707-539OT","article-title":"Cystic Fibrosis Foundation Pulmonary Guidelines. Use of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy in Patients with Cystic Fibrosis","volume":"15","author":"Ren","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.ymthe.2025.12.040_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-0042-1758731","article-title":"Advanced Cystic Fibrosis Lung Disease and Lung Transplantation in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulators","volume":"44","author":"O'Carroll","year":"2023","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib10","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/ppul.25285","article-title":"Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype","volume":"56","author":"McGarry","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib11","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1513\/AnnalsATS.201701-058OC","article-title":"An Observational Study of Outcomes and Tolerances in Patients with Cystic Fibrosis Initiated on Lumacaftor\/Ivacaftor","volume":"14","author":"Jennings","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.ymthe.2025.12.040_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41467-023-36244-2","article-title":"Future therapies for cystic fibrosis","volume":"14","author":"Allen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.040_bib13","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.ymthe.2018.05.014","article-title":"Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis","volume":"26","author":"Robinson","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib14","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/acsnano.2c05647","article-title":"Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation","volume":"16","author":"Kim","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.12.040_bib15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1126\/science.adk9428","article-title":"In vivo editing of lung stem cells for durable gene correction in mice","volume":"384","author":"Sun","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.040_bib16","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jcf.2023.04.008","article-title":"Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1\/2 clinical study","volume":"22","author":"Rowe","year":"2023","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymthe.2025.12.040_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102313","article-title":"Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications","volume":"35","author":"Eftekhari","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.12.040_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib19","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41587-024-02490-y","article-title":"Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy","volume":"43","author":"Witten","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108546","article-title":"Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors","volume":"81","author":"Yao","year":"2025","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ymthe.2025.12.040_bib21","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.040_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jconrel.2023.12.012","article-title":"Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol","volume":"366","author":"Neary","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.12.040_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2006-0184TR","article-title":"Cystic fibrosis mouse models","volume":"36","author":"Guilbault","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1165\/rcmb.2013-0261OC","article-title":"Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets","volume":"50","author":"Sun","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib25","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI43052","article-title":"Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis","volume":"120","author":"Sun","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.12.040_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7531","article-title":"In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis","volume":"11","author":"Sun","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/humc.2014.154","article-title":"Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy","volume":"26","author":"Yan","year":"2015","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.040_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1164\/rccm.201708-1616OC","article-title":"Infection Is Not Required for Mucoinflammatory Lung Disease in CFTR-Knockout Ferrets","volume":"197","author":"Rosen","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib29","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jcf.2017.09.001","article-title":"Animal and model systems for studying cystic fibrosis","volume":"17","author":"Rosen","year":"2018","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ymthe.2025.12.040_bib30","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41586-023-06549-9","article-title":"Transgenic ferret models define pulmonary ionocyte diversity and function","volume":"621","author":"Yuan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.040_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01581-2021","article-title":"Evaluation of a novel CFTR potentiator in COPD ferrets with acquired CFTR dysfunction","volume":"60","author":"Kaza","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymthe.2025.12.040_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186984","article-title":"Use of ferrets for electrophysiologic monitoring of ion transport","volume":"12","author":"Kaza","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.12.040_bib33","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87536","article-title":"A ferret model of COPD-related chronic bronchitis","volume":"1","author":"Raju","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymthe.2025.12.040_bib34","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5258727","article-title":"Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences","volume":"2016","author":"Lavelle","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymthe.2025.12.040_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1165\/rcmb.2022-0280OC","article-title":"Sonic Hedgehog Signaling Is Essential for Pulmonary Ionocyte Specification in Human and Ferret Airway Epithelia","volume":"69","author":"Cai","year":"2023","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1165\/rcmb.2006-0286OC","article-title":"Bioelectric properties of chloride channels in human, pig, ferret, and mouse airway epithelia","volume":"36","author":"Liu","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib37","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/hum.2022.036","article-title":"Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells","volume":"33","author":"Yan","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib38","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.040_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtn.2022.02.020","article-title":"Development of an mRNA replacement therapy for phenylketonuria","volume":"28","author":"Perez-Garcia","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.12.040_bib40","article-title":"Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model","volume":"32","author":"Diaz-Trelles","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymthe.2025.12.040_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/14760584.2025.2487542","article-title":"Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1\/2\/3 randomized clinical study","volume":"24","author":"Ho","year":"2025","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.ymthe.2025.12.040_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103428","article-title":"Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study","volume":"87","author":"Giles","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ymthe.2025.12.040_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1473-3099(23)00650-3","article-title":"Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"24","author":"Oda","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2025.12.040_bib44","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymthe.2024.11.020","article-title":"Lipid Nanoparticle Delivery of TALEN mRNA Targeting LPA Causes Gene Disruption and Plasma Lipoprotein(a) Reduction in Transgenic Mice","volume":"33","author":"Garcia","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib45","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.040_bib47","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-018-0394-6","article-title":"A single-cell atlas of the airway epithelium reveals the CFTR-rich pulmonary ionocyte","volume":"560","author":"Plasschaert","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.040_bib48","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1164\/rccm.202505-1242OC","article-title":"Ionocyte CFTR Coordinates Chloride Absorption and Secretion to Balance Airway Fluid","volume":"211","author":"Yuan","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/hum.2024.215","article-title":"Novel Cystic Fibrosis Ferret Model Enables Visualization of CFTR Expression Cells and Genetic CFTR Reactivation","volume":"36","author":"Yuan","year":"2025","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib50","series-title":"IEEE 19th International Symposium on Biomedical Imaging (ISBI)","first-page":"1","article-title":"Measurement of Mucociliary Transport: Novel Application of Positron Emission Tomography","author":"Stewart","year":"2022"},{"key":"10.1016\/j.ymthe.2025.12.040_bib51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1089\/hum.2020.013","article-title":"Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease","volume":"31","author":"Tang","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib52","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1164\/rccm.202008-3198OC","article-title":"Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia","volume":"203","author":"Okuda","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000155","article-title":"CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium","volume":"7","author":"Zhang","year":"2009","journal-title":"Plos Biol."},{"key":"10.1016\/j.ymthe.2025.12.040_bib54","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/hum.2015.001","article-title":"Optimization of Recombinant Adeno-Associated Virus-Mediated Expression for Large Transgenes, Using a Synthetic Promoter and Tandem Array Enhancers","volume":"26","author":"Yan","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib55","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ymthe.2004.08.009","article-title":"Dual therapeutic utility of proteasome modulating agents for pharmaco-gene therapy of the cystic fibrosis airway","volume":"10","author":"Zhang","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib56","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.0813365106","article-title":"Directed evolution of adeno-associated virus to an infectious respiratory virus","volume":"106","author":"Excoffon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.040_bib57","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/mt.2013.92","article-title":"A novel chimeric adenoassociated virus 2\/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia","volume":"21","author":"Yan","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib58","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1172\/JCI8390","article-title":"Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect","volume":"104","author":"Wang","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.12.040_bib59","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/mt.2010.13","article-title":"Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes","volume":"18","author":"Mitomo","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2015.34","article-title":"Testing gene therapy vectors in human primary nasal epithelial cultures","volume":"2","author":"Cao","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.040_bib61","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1038\/sj.mt.6300210","article-title":"Activation of CFTR-specific T Cells in cystic fibrosis mice following gene transfer","volume":"15","author":"Limberis","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.040_bib62","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1021\/acsnano.3c09028","article-title":"Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles with Rapid Tissue Clearance","volume":"18","author":"Holland","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.12.040_bib63","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1183\/09031936.00031107","article-title":"Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?","volume":"30","author":"van der Giessen","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymthe.2025.12.040_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/rccm.201802-0245OC","article-title":"An Improved Inhaled Mucolytic to Treat Airway Muco-obstructive Diseases","volume":"199","author":"Ehre","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2025.12.040_bib65","doi-asserted-by":"crossref","first-page":"12992","DOI":"10.1021\/acs.jmedchem.0c01407","article-title":"Property-Driven Design and Development of Lipids for Efficient Delivery of siRNA","volume":"63","author":"Rajappan","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymthe.2025.12.040_bib66","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/s41598-018-37192-4","article-title":"Highly Efficient Transgenesis in Ferrets Using CRISPR\/Cas9-Mediated Homology-Independent Insertion at the ROSA26 Locus","volume":"9","author":"Yu","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.12.040_bib67","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2025.12.040_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-03309-9","article-title":"Laminar fluid ejection device enables high yield and preservation of mRNA and SaRNA LNP formulations","volume":"15","author":"Ho","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2025.12.040_bib69","doi-asserted-by":"crossref","first-page":"R88","DOI":"10.1093\/hmg\/ddz139","article-title":"Advances in gene therapy for cystic fibrosis lung disease","volume":"28","author":"Yan","year":"2019","journal-title":"Hum. Mol. Genet."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:37:00Z","timestamp":1775057820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1525001625010639"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.040","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LUNAR LNP delivery of CFTR mRNA restores channel function and improves mucociliary clearance in ferret cystic fibrosis airways","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}